Results 21 to 30 of about 87,709 (275)

α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy

Therapeutic Advances in Respiratory Disease, 2014
α1 Antitrypsin deficiency (AATD) increases the risk of chronic obstructive pulmonary disease (COPD), liver disease and other conditions. Although it is not a rare disease, it is a condition rarely diagnosed because of unawareness by most healthcare ...
Michael A. Campos, Jorge Lascano
doaj   +2 more sources

Atypical antipsychotics as augmentation therapy in anorexia nervosa.

PLoS ONE, 2015
Anorexia nervosa (AN) is a life-threatening and difficult to treat mental illness with the highest mortality rates of any psychiatric disorder. We aimed to garner preliminary data on the real-world use of olanzapine and aripiprazole as augmentation ...
Enrica Marzola, Nadia Desedime, Cristina Giovannone, Federico Amianto, Secondo Fassino, Giovanni Abbate-Daga   +5 more
doaj   +3 more sources

Self-administration of augmentation therapy for alpha 1-antitrypsin deficiency. [PDF]

IJTLD Open
Self-administration of augmentation therapy for alpha 1-antitrypsin ...
Vianello A, Lococo S, Corda L, Torrazza M, Zuccarini G, Baderna P, Cinetto F, Bargagli E, Confalonieri P, Sanduzzi Zamparelli S, Bertagna De Marchi L, Molena B, Lionello F, Caminati M, Guarnieri G.   +14 more
europepmc   +3 more sources

Alpha-1 Antitrypsin Deficiency: Home Therapy

Frontiers in Pharmacology, 2021
While available in only a few countries, home therapy is a possible strategy for the treatment of alpha-1 antitrypsin deficiency. We want to describe our experience in the management of human alpha-1 antitrypsin using home care intravenous augmentation ...
Anna Annunziata, Maurizia Lanza, Antonietta Coppola, Paolo Andreozzi, Sara Spinelli, Giuseppe Fiorentino   +5 more
doaj   +1 more source

Alveolar ridge preservation reduces the need for ancillary bone augmentation in the context of implant therapy [PDF]

, 2022
BACKGROUND: There is limited information on the need for bone augmentation in the context of delayed implant placement whether alveolar ridge preservation (ARP) is previously performed or not.
Emilio Couso‐Queiruga, Mansouri, Cyrus J, Galindo-Moreno, Pablo, Gustavo Avila‐Ortiz, Alade, Azeez A., Allareddy, Trishul V., Trishul V. Allareddy, Azeez A. Alade, Couso‐Queiruga, Emilio, Allareddy, Trishul V, Galindo‐Moreno, Pablo, Avila‐Ortiz, Gustavo, Alade, Azeez A, Cyrus J. Mansouri, Couso-Queiruga, Emilio, Pablo Galindo‐Moreno, Avila-Ortiz, Gustavo, Mansouri, Cyrus J.   +17 more
core   +1 more source

Alpha-1 Antitrypsin Deficiency-Associated Clinical Manifestations and Healthcare Resource Use in the United States

COPD, 2021
Pulmonary events (PEs) associated with alpha-1 antitrypsin deficiency (AATD) can have a severe clinical course and increase healthcare resource use (HRU). However, AATD-associated HRU and healthcare costs have not been extensively described.
Ernesto Mayen Herrera, Corey Joseph, Emily S. Brouwer, Vivek Gandhi, Michael Czorniak   +4 more
doaj   +1 more source

Pindolol augmentation of antidepressant therapy [PDF]

British Journal of Psychiatry, 1998
BackgroundAntidepressant therapy is not always effective and is slow to take effect. In theory, these shortfalls may be caused by induction of neuronal negative feedback via pre-synaptic 5-HTIA receptors. Pindolol, an antagonist at somatodentritic pre-synaptic 5-HTIA receptors has been investigated as a potential accelerator and augmenter of ...
R, McAskill, S, Mir, D, Taylor
openaire   +3 more sources

Augmenting Exposure Therapy: Mobile Augmented Reality for Specific Phobia [PDF]

Frontiers in Virtual Reality, 2020
New technologies, such as virtual reality (VR) and augmented reality (AR), can be used as an add-on to exposure therapy for common anxiety disorders. While the benefits of VR for exposure therapy have already been demonstrated extensively in research, AR applications are only just becoming widely available.
De Witte, Nele, Scheveneels, Sara, Sels, Romy, Debard, Glen, Hermans, Dirk, Van Daele, Tom   +5 more
openaire   +1 more source

Case report: Self-administration of alpha-1 antitrypsin therapy: a report of two cases

Frontiers in Pharmacology, 2023
Intravenous augmentation therapy with human alpha-1 proteinase inhibitor for the management of respiratory disease is recommended for people with alpha-1 antitrypsin deficiency (AATD) who are nonsmokers or former smokers.
Ana M. Escribano Dueñas, Mónica Martín García, Begoña Tortajada Goitia, José Javier Arenas Villafranca   +3 more
doaj   +1 more source

Moving beyond first-line treatment options for OCD [PDF]

Mental Health Clinician, 2022
OCD is characterized by obsessions and compulsions that cause distress, are time-consuming, and interfere with a patient's social, occupational, or other areas of functioning.
Chris Paxos, PharmD, BCGP, BCPS, BCPP
doaj   +1 more source